首页> 外文期刊>Cardiology clinics >Apolipoprotein L1, Cardiovascular Disease and Hypertension More Questions than Answers
【24h】

Apolipoprotein L1, Cardiovascular Disease and Hypertension More Questions than Answers

机译:载脂蛋白L1,心血管疾病和高血压比答案更多的问题

获取原文
获取原文并翻译 | 示例
       

摘要

Ethnic disparities in health outcomes exist among multiple complex diseases especially cardiovascular disease, hypertension, and kidney disease. Recent discoveries in genetics have taught us that these disparities go beyond environmental and socioeconomic factors. The discovery of ethnic-specific risk variants in the Apolipoprotein L1 (APOL1) gene on chromosome 22 seen only in individuals of recent African ancestry explains a large proportion of kidney disease disparities. In addition, recent large-scale genotype-phenotype association studies have identified associations with cardiovascular disease and hypertension. This review aims to review the recent literature in this field and point toward future directions for research.
机译:在多重复杂疾病中存在尤其存在卫生疾病的族裔差异,特别是心血管疾病,高血压和肾脏疾病。 最近遗传学的发现教授这些差异超出了环境和社会经济因素。 在迄今为止近期祖先的个体中观察到载脂蛋白L1(APOL1)基因的种族特异性风险变体的发现仅解释了肾病差异的大部分。 此外,最近的大型基因型 - 表型协会研究已经确定了具有心血管疾病和高血压的关联。 该评论旨在审查该领域最近的文献,并指出未来的研究方向。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号